Laura Grabel, the Lauren B. Dachs Professor of Science and Society, professor of biology, warns in a new op-ed that the progress of embryonic stem cell research in this country, always subject to the ups and down of politics, is currently under threat.
Co-authored with Diane Krause of Yale University, the op-ed in The Hartford Courant notes that Tom Price, President Donald Trump’s nominee to head the Department of Health and Human Services, is on record opposing embryonic stem cell research. They write:
As stem cell researchers, we fear that this appointment would endanger human embryonic stem cell research in the United States and reverse the substantial progress made in recent years. There are promising clinical trials underway for macular degeneration, spinal cord injury and diabetes with more possible, including for Parkinson’s disease.
The authors explain what has made this research so controversial, and argue why it is singularly valuable in its potential to treat life-threatening diseases and injuries.
Grabel also is professor of environmental studies, professor of feminist, gender and sexuality studies.